Overview
Dysraphic spinal cord lipoma, also known as spinal lipoma associated with spinal dysraphism, is a congenital malformation in which a fatty mass (lipoma) is abnormally attached to or incorporated within the spinal cord, arising from a defect in neural tube closure during embryonic development. This condition falls within the spectrum of closed spinal dysraphism (occult spinal dysraphism), meaning the overlying skin is typically intact, unlike open neural tube defects such as myelomeningocele. The lipoma may be classified based on its anatomical relationship to the spinal cord and may include lipomyelomeningocele, lipomyelocele, or intradural lipoma subtypes. The condition primarily affects the nervous system and musculoskeletal system. The lipoma tethers the spinal cord, restricting its normal movement within the spinal canal, which can lead to progressive neurological deterioration as the child grows. Key clinical features include lower limb weakness or asymmetry, sensory deficits, bladder and bowel dysfunction (neurogenic bladder and bowel), foot deformities (such as clubfoot or cavus foot), and back pain. A subcutaneous fatty mass or skin stigmata (such as a dimple, hairy patch, or skin tag) in the lumbosacral region is often the first visible sign, frequently noted at birth or in early childhood. Some patients may remain asymptomatic for years before symptoms develop due to progressive cord tethering. Management typically involves neurosurgical evaluation and, in many cases, prophylactic or therapeutic surgical untethering of the spinal cord to prevent or halt neurological decline. Surgery aims to debulk the lipoma and release the tethered cord, though complete removal is often not possible due to the intimate relationship between the lipoma and neural tissue. Urological assessment and management of neurogenic bladder are important components of care. Orthopedic interventions may be needed for associated skeletal deformities. Long-term follow-up is essential, as re-tethering can occur after surgery, and some patients may require repeat procedures. The decision to operate on asymptomatic patients remains a topic of ongoing clinical discussion.
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Dysraphic spinal cord lipoma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Dysraphic spinal cord lipoma at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Dysraphic spinal cord lipoma.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Dysraphic spinal cord lipoma.
Community
No community posts yet. Be the first to share your experience with Dysraphic spinal cord lipoma.
Start the conversation →Latest news about Dysraphic spinal cord lipoma
No recent news articles for Dysraphic spinal cord lipoma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Dysraphic spinal cord lipoma
What is Dysraphic spinal cord lipoma?
Dysraphic spinal cord lipoma, also known as spinal lipoma associated with spinal dysraphism, is a congenital malformation in which a fatty mass (lipoma) is abnormally attached to or incorporated within the spinal cord, arising from a defect in neural tube closure during embryonic development. This condition falls within the spectrum of closed spinal dysraphism (occult spinal dysraphism), meaning the overlying skin is typically intact, unlike open neural tube defects such as myelomeningocele. The lipoma may be classified based on its anatomical relationship to the spinal cord and may include li
How is Dysraphic spinal cord lipoma inherited?
Dysraphic spinal cord lipoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Dysraphic spinal cord lipoma typically begin?
Typical onset of Dysraphic spinal cord lipoma is neonatal. Age of onset can vary across affected individuals.